These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22954446)

  • 1. Identification and characterization of four process-related impurities in retigabine.
    Wang X; Zhou H; Zheng J; Huang C; Liu W; Yu L; Zeng S
    J Pharm Biomed Anal; 2012 Dec; 71():148-51. PubMed ID: 22954446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine.
    Douša M; Srbek J; Rádl S; Cerný J; Klecán O; Havlíček J; Tkadlecová M; Pekárek T; Gibala P; Nováková L
    J Pharm Biomed Anal; 2014 Jun; 94():71-6. PubMed ID: 24552644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, identification and structure elucidation of two novel process-related impurities of retigabine.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Oct; 99():22-7. PubMed ID: 25047423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry.
    Sun C; Xu H; Pan Y; Shen Z; Wang D
    Rapid Commun Mass Spectrom; 2007; 21(17):2889-94. PubMed ID: 17663502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR.
    Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q; Yao L
    J Pharm Biomed Anal; 2016 Jan; 117():325-32. PubMed ID: 26412721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, synthesis and quantification of process-related impurities in auraptene.
    Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
    J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n).
    Thomas S; Paul SK; Shandilya S; Agarwal A; Saxena N; Awasthi AK; Matta Hb; Vir D; Mathela CS
    Analyst; 2012 Aug; 137(15):3571-82. PubMed ID: 22733388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.